Dachaigh › Galar Graft-versus-Host
Sgrùdaidhean clionaigeach Galar Graft-versus-Host a’ fastadh anns na SA
Tha 34 sgrùdaidhean airson Galar Graft-versus-Host a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Boston, MA10 sgrùdaidhean
- New York City, NY7 sgrùdaidhean
- Columbus, OH6 sgrùdaidhean
- Atlanta, GA5 sgrùdaidhean
- Washington, DC5 sgrùdaidhean
- Tampa, FL4 sgrùdaidhean
- Detroit, MI4 sgrùdaidhean
- Pittsburgh, PA4 sgrùdaidhean
- Portland, OR4 sgrùdaidhean
- Baldwin Park, CA4 sgrùdaidhean
- St. Louis, MO4 sgrùdaidhean
- Miami, FL4 sgrùdaidhean
- Queens, NY4 sgrùdaidhean
- Seattle, WA4 sgrùdaidhean
- Nashville, TN3 sgrùdaidhean
- Cleveland, OH3 sgrùdaidhean
- Chicago, IL3 sgrùdaidhean
- Los Angeles, CA3 sgrùdaidhean
- Edison, NJ3 sgrùdaidhean
- East Norwalk, CT3 sgrùdaidhean
- Greenburgh, NY3 sgrùdaidhean
- New Rochelle, NY3 sgrùdaidhean
- Staten Island, NY3 sgrùdaidhean
- Houston, TX3 sgrùdaidhean
Le stàit
- California9 sgrùdaidhean
- Florida7 sgrùdaidhean
- Georgia5 sgrùdaidhean
- Illinois3 sgrùdaidhean
- Kansas3 sgrùdaidhean
- Maryland5 sgrùdaidhean
- Massachusetts10 sgrùdaidhean
- Michigan5 sgrùdaidhean
- Missouri4 sgrùdaidhean
- New Jersey4 sgrùdaidhean
- New York10 sgrùdaidhean
- Ohio7 sgrùdaidhean
- Oregon4 sgrùdaidhean
- Pennsylvania6 sgrùdaidhean
- Tennessee3 sgrùdaidhean
- Texas4 sgrùdaidhean
- Washington4 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 18 gu 60 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT00001529Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 70 · Banairean · Air ùrachadh 29 Sult 2026 · NCT06649201Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
A’ fastadhÌre 1/2
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT05531786Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06910969Evaluation of Patients With Immune Function Abnormalities
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Gach aois · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT00128973Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 7 gu 80 · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT00106925Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Lùna 2026 · NCT06450925Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia
A’ fastadhÌre 1
Aoisean 18 gu 90 · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT06392711Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT07565220Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD
A’ fastadhÌre 1
Aoisean 2 agus nas sine · Gach gnè · Air ùrachadh 23 Iuch 2026 · NCT06991361A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT07359859Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT07216443Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
A’ fastadhÌre 1
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 1 Iuch 2026 · NCT06996119A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT07006506Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT06815003A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
A’ fastadhÌre 2
Aoisean 2 agus nas sine · Gach gnè · Air ùrachadh 16 Ògmh 2026 · NCT04710576Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD)
A’ fastadhÌre 1/2
Aoisean 14 gu 100 · Gach gnè · Air ùrachadh 29 Cèit 2026 · NCT05289167A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant
A’ fastadhÌre 2
Aoisean 4 agus nas sine · Gach gnè · Air ùrachadh 22 Cèit 2026 · NCT05675930A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Cèit 2026 · NCT06615050Cord Blood Transplantation in Children and Young Adults With Blood Cancer
A’ fastadhÌre 2
Suas gu aois 26 · Gach gnè · Air ùrachadh 14 Cèit 2026 · NCT07566377Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
A’ fastadhÌre 2
Aoisean 2 agus nas sine · Gach gnè · Air ùrachadh 11 Cèit 2026 · NCT04380740Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Gibl 2026 · NCT06008808Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Gibl 2026 · NCT07356245Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Gibl 2026 · NCT06434363A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant
A’ fastadh
Suas gu aois 30 · Gach gnè · Air ùrachadh 13 Gibl 2026 · NCT04337515Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.